<?xml version="1.0" encoding="UTF-8"?>
<p id="p0140">Researchers who previously assessed the viability of HEPG2 cells and ETBr cells treated with CET found that CET is not cytotoxic and whereas they induced dose-dependent anti-HBV and anti-bovine viral diarrhoea virus (BVDV) as a surrogate for HCV effects, respectively [
 <xref rid="bib16" ref-type="bibr">16</xref>]. Our results also demonstrated that CET possesses low cytotoxicity and does not affect cell viability (
 <xref rid="fig2" ref-type="fig">Fig. 2</xref>A). Moreover, viral RNA levels, protein expression levels, and viral titers (
 <xref rid="fig2" ref-type="fig">Fig. 2</xref>B, C, and 2D) in CET-treated Vero cells revealed that 20–80 μM CET led to &gt;50–90% virus inhibition, consistent with previous findings.
</p>
